RPAM
Rhenman & Partners Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.4M | Sell |
61,455
-5,295
| -8% | -$2.36M | 3.46% | 3 |
|
|
2025
Q1 | $32.4M | Buy |
66,750
+16,750
| +34% | +$8.12M | 3.72% | 3 |
|
|
2024
Q4 | $20.1M | Buy |
50,000
+2,250
| +5% | +$906K | 2.07% | 15 |
|
|
2024
Q3 | $22.2M | Sell |
47,750
-6,250
| -12% | -$2.91M | 1.8% | 23 |
|
|
2024
Q2 | $25.3M | Sell |
54,000
-2,500
| -4% | -$1.17M | 2.43% | 14 |
|
|
2024
Q1 | $23.6M | Sell |
56,500
-38,500
| -41% | -$16.1M | 2.24% | 16 |
|
|
2023
Q4 | $38.7M | Buy |
95,000
+18,500
| +24% | +$7.53M | 3.86% | 4 |
|
|
2023
Q3 | $26.6M | Buy |
76,500
+13,000
| +20% | +$4.52M | 2.87% | 7 |
|
|
2023
Q2 | $22.3M | Sell |
63,500
-20,000
| -24% | -$7.04M | 2.36% | 14 |
|
|
2023
Q1 | $26.1M | Buy |
83,500
+3,500
| +4% | +$1.09M | 2.86% | 5 |
|
|
2022
Q4 | $23.1M | Sell |
80,000
-16,000
| -17% | -$4.62M | 2.41% | 9 |
|
|
2022
Q3 | $30M | Buy |
96,000
+1,000
| +1% | +$312K | 3.14% | 4 |
|
|
2022
Q2 | $26.8M | Buy |
95,000
+5,500
| +6% | +$1.55M | 3.04% | 9 |
|
|
2022
Q1 | $23.4M | Sell |
89,500
-75,500
| -46% | -$19.7M | 2.3% | 10 |
|
|
2021
Q4 | $36.7M | Hold |
165,000
| – | – | 2.44% | 12 |
|
|
2021
Q3 | $29.9M | Sell |
165,000
-50,897
| -24% | -$9.23M | 2.1% | 13 |
|
|
2021
Q2 | $43.5M | Buy |
215,897
+47,476
| +28% | +$9.57M | 2.95% | 3 |
|
|
2021
Q1 | $36.2M | Buy |
168,421
+53,421
| +46% | +$11.5M | 2.52% | 7 |
|
|
2020
Q4 | $27.2M | Buy |
115,000
+5,000
| +5% | +$1.18M | 2.22% | 11 |
|
|
2020
Q3 | $29.9M | Sell |
110,000
-27,500
| -20% | -$7.48M | 2.66% | 5 |
|
|
2020
Q2 | $39.9M | Buy |
137,500
+22,500
| +20% | +$6.53M | 4.31% | 2 |
|
|
2020
Q1 | $27.4M | Sell |
115,000
-45,000
| -28% | -$10.7M | 3.83% | 2 |
|
|
2019
Q4 | $35M | Sell |
160,000
-26,000
| -14% | -$5.69M | 3.84% | 2 |
|
|
2019
Q3 | $31.5M | Buy |
186,000
+768
| +0.4% | +$130K | 3.95% | 1 |
|
|
2019
Q2 | $34M | Buy |
185,232
+40,832
| +28% | +$7.49M | 3.74% | 1 |
|
|
2019
Q1 | $26.6M | Buy |
144,400
+11,975
| +9% | +$2.2M | 3.11% | 3 |
|
|
2018
Q4 | $21.9M | Sell |
132,425
-10,040
| -7% | -$1.66M | 2.51% | 8 |
|
|
2018
Q3 | $27.5M | Sell |
142,465
-12,535
| -8% | -$2.42M | 2.75% | 4 |
|
|
2018
Q2 | $26.3M | Buy |
155,000
+5,000
| +3% | +$850K | 2.7% | 3 |
|
|
2018
Q1 | $24.4M | Sell |
150,000
-2,204
| -1% | -$359K | 3.01% | 4 |
|
|
2017
Q4 | $22.8M | Sell |
152,204
-27,796
| -15% | -$4.17M | 3.08% | 5 |
|
|
2017
Q3 | $27.4M | Buy |
180,000
+84,987
| +89% | +$12.9M | 3.49% | 2 |
|
|
2017
Q2 | $12.2M | Hold |
95,013
| – | – | 1.76% | 21 |
|
|
2017
Q1 | $10.4M | Buy |
95,013
+30,000
| +46% | +$3.28M | 1.65% | 24 |
|
|
2016
Q4 | $4.79M | Sell |
65,013
-15,000
| -19% | -$1.11M | 0.92% | 43 |
|
|
2016
Q3 | $6.98M | Buy |
80,013
+20,013
| +33% | +$1.75M | 1.11% | 32 |
|
|
2016
Q2 | $5.16M | Sell |
60,000
-18,000
| -23% | -$1.55M | 0.92% | 44 |
|
|
2016
Q1 | $6.2M | Buy |
78,000
+22,000
| +39% | +$1.75M | 1.23% | 35 |
|
|
2015
Q4 | $7.05M | Sell |
56,000
-49,000
| -47% | -$6.17M | 1.07% | 37 |
|
|
2015
Q3 | $10.9M | Buy |
105,000
+50,000
| +91% | +$5.21M | 1.74% | 23 |
|
|
2015
Q2 | $6.79M | Sell |
55,000
-3,000
| -5% | -$370K | 0.82% | 39 |
|
|
2015
Q1 | $6.84M | Buy |
58,000
+20,000
| +53% | +$2.36M | 1.15% | 29 |
|
|
2014
Q4 | $4.51M | Sell |
38,000
-5,000
| -12% | -$594K | 1.31% | 27 |
|
|
2014
Q3 | $4.83M | Sell |
43,000
-58,600
| -58% | -$6.58M | 1.41% | 20 |
|
|
2014
Q2 | $9.62M | Buy |
+101,600
| New | +$9.62M | 2.85% | 6 |
|